跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 87 条关于
“MHLW”
全部
87
临床试验
5
药物
1
机构
0
资讯
81
去年
Japan Approves GSK's Arexvy for RSV Prevention in Adults Aged 50-59 at Increased Risk
2年前
Japan Approves CSL and Arcturus' Self-Amplifying mRNA COVID-19 Vaccine, Kostaive
去年
Takeda's HYQVIA Approved in Japan for Agammaglobulinemia and Hypogammaglobulinemia
2年前
Chugai Seeks Approval in Japan for Vabysmo to Treat Angioid Streaks
去年
GSK's Arexvy Receives Expanded Approval in Japan for RSV Prevention in Adults Aged 50-59
前天
Japan's MHLW Approves Lundbeck's Vyepti (eptinezumab), the Only IV CGRP-Targeted Migraine Preventive in the Country
去年
Japan Prioritizes 14 "Drug Loss" Products for Urgent Domestic Development to Address Critical Medical Needs
去年
VYVDURA Approved in Japan for Chronic Inflammatory Demyelinating Polyneuropathy
9个月前
Guardant Health Japan Secures First ESR1 Mutation Liquid Biopsy Approval for Breast Cancer Treatment Selection
25天前
Japan Approves BRINSUPRI (brensocatib) as First-in-Class Treatment for Non-Cystic Fibrosis Bronchiectasis
第 1 页,共 9 页
上一页
下一页